Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
05/2003
05/27/2003US6569882 Viricides; enzyme inhibitors
05/27/2003US6569876 Method and structure for inhibiting activity of serine elastases
05/22/2003WO2003042171A1 Vitamin d derivatives with acyloxy groups at the 24-position of the side chain, a method for producing the same and use thereof in production of medicaments
05/22/2003WO2003041658A2 Process for the preparation of 3,7-disubstituted-2,3,4,5- tetrahydro-1h-1,4-benzodiazepine compounds
05/22/2003WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003WO2002100327A3 Substituted 1-benzazepines and derivatives thereof
05/22/2003US20030097011 Novel carbamate-based cationic lipids
05/22/2003US20030097005 Method for the preparation of enantiomerically enriched compounds
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003US20030096998 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections
05/22/2003US20030096931 Process for the preparation of alkylimidazolidone (meth)acrylates
05/22/2003US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite
05/22/2003US20030096844 Cannabinoid receptor ligands
05/22/2003US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
05/22/2003US20030096826 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003US20030096765 Aromatic esters; cytotoxic agents; antitumor agents
05/22/2003US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots
05/22/2003CA2466115A1 Cyanoalkylamino derivatives as protease inhibitors
05/21/2003EP1312602A1 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311489A1 Biphenyl derivatives and the use thereof as integrin inhibitors
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1311471A1 Phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines
05/21/2003EP1311302A2 Pharmaceuticals for the imaging of angiogenic disorders
05/21/2003EP1283711A4 Peptide deformylase inhibitors
05/21/2003EP0973397B1 Novel fungicide composition containing a 2-imidazoline-5-one
05/21/2003EP0971709B1 Novel compounds useful as neuro-protective agents
05/21/2003CN1419547A Compounds exhibiting thrombopoietin receptor agaonism
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1419536A Process for the selective N-formylation of n-hydroxylamines
05/21/2003CN1419534A Diphenyl ether compounds useful in therapie
05/21/2003CN1419450A Nitrite salts of antimicrobial agents
05/21/2003CN1418857A Novel functional fluorescent material-substituted rubrene
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/21/2003CN1109021C Method of producing N,N'-diazole compounds
05/20/2003US6566533 Reacting aza-heterocyclic compounds (indoles and carbazoles) with alkyl- or aryl-halides in the presence of carbon dioxide and alkali carbonate
05/20/2003US6566532 By reacting a cyclic acid anhydride with a hydroxy compound; imidazolidin-2-one hemiester for example, for use in synthesizing vitamin H
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock
05/20/2003US6566384 For therapy of cancer, inflammation and inflammatory diseases, tissue degeneration, periodontal disease, ophthalmological disease, dermatological disorders, fever, cardiovascular effects, haemorrhage, coagulation and acute phase response
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003US6566380 For therapy of cardiac arrhythmias
05/20/2003US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents.
05/20/2003US6566330 Positively charged non-natural amino acids, methods of making and using thereof in peptides
05/20/2003US6566034 Photographic material containing a novel hydrazine type
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/20/2003CA2322944C Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040107A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/15/2003WO2003040106A1 Preparation and use of substituted imidazoles
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2002086508A3 Elisa kit for the determination of cyp2c19 metabolic phenotypes and uses thereof
05/15/2003WO2002058730A3 Compositions for treatment of ocular neovascularization
05/15/2003US20030092754 External preparation for skin diseases containing nitroimidazole
05/15/2003US20030092741 Novel alpha adrenergic agents
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003US20030092715 Aryl and biaryl compounds having MCH modulatory activity
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003US20030091510 Administering fungicide to mucous membrane
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003CA2459745A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/14/2003EP1310494A1 PPAR (delta) ACTIVATORS
05/14/2003EP1310485A1 Pyrrole derivatives
05/14/2003EP1309595A2 Synthesis of (r)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo(1,2-a) imidazol-2-one
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP0877738B1 Process for the preparation of phenylimidazolidine derivatives
05/14/2003CN1418210A Carbocyclik side chain containing, N-substituted Metalloprotease inhibitors
05/14/2003CN1418209A Carbocyclic side chain containing metalloprotease inhibitors
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1417407A Room temperature ionic liquid containing unsaturated double bond and its prepn and application
05/14/2003CN1108292C Preparation of 2,4-imidzolidinedione
05/13/2003US6562967 Drug screening; purity
05/13/2003US6562966 Combining a racemic or a diastereomeric mixture of a chiral substrate with a nucleophile, in the presence of a chiral non-racemic catalyst
05/13/2003US6562861 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
05/13/2003US6562853 Pesticides
05/13/2003US6562846 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
05/13/2003US6562832 Substituted imidazole compounds
05/13/2003US6562813 Aralkyl and aralkylidene heterocyclic lactams and imides
05/13/2003US6562789 Histidine derivatives, preparation process, and their use as free antiradical agents
05/13/2003CA2127876C Imidazole derivatives and their use as cytokine inhibitors
05/08/2003WO2003037875A1 Developer constituents and their use for dying keratin fibers
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003US20030088103 PPARgamma modulators
05/08/2003US20030087950 New alpha-amino acid sulphonyl compounds
05/08/2003US20030087945 Sulfonylaminocarboxylic acids
05/08/2003US20030087940 Substituted imidazoles and thiazoles
05/08/2003US20030087939 Novel succinate derivative compounds useful as cysteine protease inhibitors
05/08/2003US20030087936 Treating enterovirus infection
05/08/2003US20030087928 Novel anilide compounds and drugs containing the same
05/08/2003US20030087185 Organometallic precursor for forming metal pattern and method of forming metal pattern using the same
05/08/2003US20030087151 Low melting point
1 ... 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 ... 345